These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 10692965

  • 1. How does tuberculosis relate to HIV positive and HIV negative drug users?
    Keizer ST, Langendam MM, van Deutekom H, Coutinho RA, van Ameijden EJ.
    J Epidemiol Community Health; 2000 Jan; 54(1):64-8. PubMed ID: 10692965
    [Abstract] [Full Text] [Related]

  • 2. [Tuberculosis in HIV-positive and HIV-negative drug users in Amsterdam].
    Keizer ST, Langendam MW, van Deutekom H, Coutinho RA, van Ameijden FJ.
    Ned Tijdschr Geneeskd; 1998 Jan 24; 142(4):184-9. PubMed ID: 9557024
    [Abstract] [Full Text] [Related]

  • 3. Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary Complications of HIV Infection Study Group.
    Markowitz N, Hansen NI, Hopewell PC, Glassroth J, Kvale PA, Mangura BT, Wilcosky TC, Wallace JM, Rosen MJ, Reichman LB.
    Ann Intern Med; 1997 Jan 15; 126(2):123-32. PubMed ID: 9005746
    [Abstract] [Full Text] [Related]

  • 4. A prospective study of the risk of tuberculosis among HIV-infected patients.
    Guelar A, Gatell JM, Verdejo J, Podzamczer D, Lozano L, Aznar E, Miró JM, Mallolas J, Zamora L, González J.
    AIDS; 1993 Oct 15; 7(10):1345-9. PubMed ID: 8267907
    [Abstract] [Full Text] [Related]

  • 5. Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA).
    Antonucci G, Girardi E, Raviglione MC, Ippolito G.
    JAMA; 1995 Jul 12; 274(2):143-8. PubMed ID: 7596002
    [Abstract] [Full Text] [Related]

  • 6. Tuberculosis risk varies with the duration of HIV infection: a prospective study of European drug users with known date of HIV seroconversion.
    van Asten L, Langendam M, Zangerle R, Hernández Aguado I, Boufassa F, Schiffer V, Brettle RP, Robertson JR, Fontanet A, Coutinho RA, Prins M.
    AIDS; 2003 May 23; 17(8):1201-8. PubMed ID: 12819522
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
    Graham NM, Galai N, Nelson KE, Astemborski J, Bonds M, Rizzo RT, Sheeley L, Vlahov D.
    Arch Intern Med; 1996 Apr 22; 156(8):889-94. PubMed ID: 8774208
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Incidence of tuberculosis in injection drug users in San Francisco: impact of anergy.
    Daley CL, Hahn JA, Moss AR, Hopewell PC, Schecter GF.
    Am J Respir Crit Care Med; 1998 Jan 22; 157(1):19-22. PubMed ID: 9445273
    [Abstract] [Full Text] [Related]

  • 11. Incidence and spectrum of severe medical complications among hospitalized HIV-seronegative and HIV-seropositive narcotic drug users.
    Scheidegger C, Zimmerli W.
    AIDS; 1996 Oct 22; 10(12):1407-14. PubMed ID: 8902071
    [Abstract] [Full Text] [Related]

  • 12. Tuberculin skin testing in intravenous drug users: differences between HIV-seropositive and HIV-seronegative subjects.
    Portu JJ, Aldamiz-Etxebarria M, Agud JM, Arévalo JM, Almaraz MJ, Ayensa C.
    Addict Biol; 2002 Apr 22; 7(2):235-41. PubMed ID: 12006219
    [Abstract] [Full Text] [Related]

  • 13. [Risk of tuberculosis in a cohort of HIV positive IVDA patients in relation to the degree of immunodeficiency and tuberculosis skin test].
    Cabarcos Ortíz de Barrón A, Barrio Gómez E, Lado Lado FL, Lorenzo Zúñiga V.
    An Med Interna; 2000 Sep 22; 17(9):465-70. PubMed ID: 11100532
    [Abstract] [Full Text] [Related]

  • 14. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy.
    Selwyn PA, Sckell BM, Alcabes P, Friedland GH, Klein RS, Schoenbaum EE.
    JAMA; 2000 Sep 22; 268(4):504-9. PubMed ID: 1619742
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Methadone maintenance treatment modalities in relation to incidence of HIV: results of the Amsterdam cohort study.
    Langendam MW, van Brussel GH, Coutinho RA, van Ameijden EJ.
    AIDS; 1999 Sep 10; 13(13):1711-6. PubMed ID: 10509573
    [Abstract] [Full Text] [Related]

  • 17. [HIV infection, tuberculosis and tuberculin test in Switzerland. The Swiss HIV Cohort Study].
    Sudre P, Rieder H, Bassetti S, Hirschel BJ, Ledergerber B, Malvy D.
    Schweiz Med Wochenschr; 1996 Nov 23; 126(47):2007-12. PubMed ID: 8984608
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis.
    Jansà JM, Serrano J, Caylà JA, Vidal R, Ocaña I, Español T.
    Int J Tuberc Lung Dis; 1998 Feb 23; 2(2):140-6. PubMed ID: 9580481
    [Abstract] [Full Text] [Related]

  • 20. Two-step tuberculin skin testing of injection drug users recruited from community-based settings.
    Lifson AR, Grant SM, Lorvick J, Pinto FD, He H, Thompson S, Keudell EG, Stark MJ, Booth RE, Watters JK.
    Int J Tuberc Lung Dis; 1997 Apr 23; 1(2):128-34. PubMed ID: 9441076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.